SMRUTHI ORGANICS
|
The Current P/E Ratio of SMRUTHI ORGANICS is 30.96.
| Share Price | ₹127.0 | Nov 25,2025 |
| Market Cap | ₹144.7 Cr | |
| Earnings-TTM | ₹4.7 Cr | TTM-Standalone Results |
| Price/Earnings | 30.96x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SMRUTHI ORGANICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹144.7 Cr] as on Nov 25,2025
(/) Earnings [ ₹4.7 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 30.96x ]
Thus, for SMRUTHI ORGANICS , the investors are currently willing to pay 30.96 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMRUTHI ORGANICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SMRUTHI ORGANICS over the last five years.
Historical PE (Price/Earnings) ratio chart of SMRUTHI ORGANICS
PE Ratio Performance Analysis for SMRUTHI ORGANICS
- SMRUTHI ORGANICS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 31.43x.
- SMRUTHI ORGANICS 's operated at median p/e ratio of 35.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SMRUTHI ORGANICS 's p/e ratio peaked in Mar2024 at 46.58x.
- SMRUTHI ORGANICS 's p/e ratio hit its five-year low in Mar2021 of 14.87x.
How does SMRUTHI ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SMRUTHI ORGANICS | 4.67 | 30.96 | 144.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.42 | 425,102.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.53 | 170,299.0 |
| CIPLA LTD | 5,453.86 | 22.32 | 121,735.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 59.23 | 126,753.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.03 | 103,155.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.40 | 92,592.0 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.77 | 93,328.2 |
| LUPIN LTD | 4,347.53 | 21.48 | 93,364.5 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.34 | 70,131.8 |
| ABBOTT INDIA LTD | 1,508.95 | 42.63 | 64,331.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMRUTHI ORGANICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.03x |
| Max industry PE | 68.53x |
| Median industry PE | 30.96x |
| Average industry PE | 35.92x |
You may also like the below Video Courses